DB Gold Double Short ETN due Feb 15 2038
2 hedge funds and large institutions have $204K invested in DB Gold Double Short ETN due Feb 15 2038 in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
3.61% less ownership
Funds ownership: 3.61% → 0% (-3.6%)
18% less capital invested
Capital invested by funds: $249K → $204K (-$45.7K)
33% less funds holding
Funds holding: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$37.1K |
| 2 |
SAM
Smartleaf Asset Management
Boston,
Massachusetts
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$380 |
| 2 |
AT
Avenir Tech
Hong Kong
|
-$4 |
DZZ Hedge Fund Activity: Q1 2026 in Review
2 of the 8,203 institutional investors tracked by Wall St. Rank reported a position in DB Gold Double Short ETN due Feb 15 2038 (DZZ) for Q1 2026, worth a combined $204K — down 18% from $249K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of DZZ and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Jane Street, adding an estimated $37.1K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $380 sold.
- 2 institutional investors held DB Gold Double Short ETN due Feb 15 2038 (DZZ) as of Q1 2026, down from 3 in Q4 2025.
- Funds reported $204K of DB Gold Double Short ETN due Feb 15 2038 stock for Q1 2026, down 18% quarter-over-quarter.
- 1 fund opened new DB Gold Double Short ETN due Feb 15 2038 positions in Q1 2026 and 2 closed out, a net change of -1 holder.
- The largest DB Gold Double Short ETN due Feb 15 2038 buyer in Q1 2026 was Jane Street, an estimated $37.1K added.
- The largest DB Gold Double Short ETN due Feb 15 2038 seller in Q1 2026 was Tower Research Capital (TRC), an estimated $380 sold.
Based on aggregated 13F filings for Q1 2026.